PROSTATE-SPECIFIC ANTIGEN OBTAINED UNDER OPTIMAL CONDITIONS DETERMINES EXTRACAPSULAR ADENOCARCINOMA OF THE PROSTATE

被引:7
作者
EHRETH, JT
MILLER, JI
MCBEATH, RB
HANSEN, KK
AHMANN, FR
DALKIN, BL
SCHIFF, M
机构
[1] UNIV ARIZONA,HLTH SCI CTR,HEMATOL ONCOL SECT,TUCSON,AZ
[2] VET AFFAIRS MED CTR,TUCSON,AZ
[3] TUCSON MED CTR,TUCSON,AZ
来源
BRITISH JOURNAL OF UROLOGY | 1995年 / 75卷 / 01期
关键词
PROSTATE CANCER; ORGAN-CONFINED; PROSTATE-SPECIFIC ANTIGEN;
D O I
10.1111/j.1464-410X.1995.tb07226.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the relationship of prostate-specific antigen (PSA) obtained under optimal conditions with the presence or absence of organ-confined prostate cancer following radical prostatectomy. Patients and methods The medical records of 300 consecutive patients who underwent radical retropubic prostatectomy were retrospectively reviewed. Ninety-three patients were excluded who had a pre-operative PSA level potentially altered by various factors (prostate infection, manipulation or instrumentation). Results A pre-operative PSA value <4 ng/mL, accurately predicted pathologically confined disease in 42 of 51 patients (82%) which contrasted with extracapsular disease in 74 of 84 patients (88%) who had a PSA value >10 ng/mL. One of the 53 patients with a PSA >15 ng/mL had organ-confined disease at surgery. Conclusion These data demonstrate that optimal serum PSA values correlate well with pathological stage.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 20 条
[1]   THE VALUE OF THE MEASUREMENT OF SERUM PROSTATE SPECIFIC ANTIGEN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND UNTREATED PROSTATE-CANCER [J].
ARMITAGE, TG ;
COOPER, EH ;
NEWLING, DWW ;
ROBINSON, MRG ;
APPLEYARD, I .
BRITISH JOURNAL OF UROLOGY, 1988, 62 (06) :584-589
[2]  
BRAWER MK, 1988, ARCH PATHOL LAB MED, V112, P1110
[3]   SCREENING FOR PROSTATIC-CARCINOMA WITH PROSTATE SPECIFIC ANTIGEN [J].
BRAWER, MK ;
CHETNER, MP ;
BEATIE, J ;
BUCHNER, DM ;
VESSELLA, RL ;
LANGE, PH .
JOURNAL OF UROLOGY, 1992, 147 (03) :841-845
[4]   PROSTATIC SPECIFIC ANTIGEN AND PROSTATIC ACID-PHOSPHATASE IN THE MONITORING AND STAGING OF PATIENTS WITH PROSTATIC-CANCER [J].
ERCOLE, CJ ;
LANGE, PH ;
MATHISEN, M ;
CHIOU, RK ;
REDDY, PK ;
VESSELLA, RL .
JOURNAL OF UROLOGY, 1987, 138 (05) :1181-1184
[5]   CLINICAL USE OF PROSTATE SPECIFIC ANTIGEN IN PATIENTS WITH PROSTATE-CANCER [J].
HUDSON, MA ;
BAHNSON, RR ;
CATALONA, WJ .
JOURNAL OF UROLOGY, 1989, 142 (04) :1011-1017
[6]   SERUM PROSTATE SPECIFIC ANTIGEN AS PRE-SCREENING TEST FOR PROSTATE-CANCER [J].
LABRIE, F ;
DUPONT, A ;
SUBURU, R ;
CUSAN, L ;
TREMBLAY, M ;
GOMEZ, JL ;
EMOND, J ;
STAMEY, TA ;
LANGE, PH .
JOURNAL OF UROLOGY, 1992, 147 (03) :846-852
[7]  
LANGE PH, 1989, J UROLOGY, V141, P874
[8]  
LINDSTEDT G, 1990, CLIN CHEM, V36, P53
[9]   PREOPERATIVE PREDICTION OF PATHOLOGICAL TUMOR VOLUME AND STAGE IN CLINICALLY LOCALIZED PROSTATE-CANCER - COMPARISON OF DIGITAL RECTAL EXAMINATION, TRANSRECTAL ULTRASONOGRAPHY AND MAGNETIC-RESONANCE-IMAGING [J].
MCSHERRY, SA ;
LEVY, F ;
SCHIEBLER, ML ;
KEEFE, B ;
DENT, GA ;
MOHLER, JL .
JOURNAL OF UROLOGY, 1991, 146 (01) :85-89
[10]   PROSTATE SPECIFIC ANTIGEN IN THE PREOPERATIVE AND POSTOPERATIVE EVALUATION OF LOCALIZED PROSTATIC-CANCER TREATED WITH RADICAL PROSTATECTOMY [J].
OESTERLING, JE ;
CHAN, DW ;
EPSTEIN, JI ;
KIMBALL, AW ;
BRUZEK, DJ ;
ROCK, RC ;
BRENDLER, CB ;
WALSH, PC .
JOURNAL OF UROLOGY, 1988, 139 (04) :766-772